Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects
NCT04146805
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
80
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Liver Disease
NASH - Nonalcoholic Steatohepatitis
Interventions
DRUG:
BLD-0409
DRUG:
Control: Placebo
Sponsor
Blade Therapeutics